BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6335590)

  • 1. The purification and biological properties of human interleukin 1.
    Lachman LB
    Symp Fundam Cancer Res; 1984; 37():171-83. PubMed ID: 6335590
    [No Abstract]   [Full Text] [Related]  

  • 2. Human interleukin 1: purification and properties.
    Lachman LB
    Fed Proc; 1983 Jun; 42(9):2639-45. PubMed ID: 6602068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification to homogeneity of biologically active human interleukin 1.
    Krakauer T
    Prep Biochem; 1984-1985; 14(5):449-70. PubMed ID: 6336003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interleukin 1: its physico-chemical properties and biological activity].
    Kowalczyk-Bronisz SH
    Postepy Hig Med Dosw; 1988; 42(4):353-78. PubMed ID: 3073379
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical heterogeneity of human interleukin-1.
    Ihrie EJ; Wood DD
    Lymphokine Res; 1985; 4(3):169-81. PubMed ID: 3875764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of human interleukin 2 produced from normal human peripheral blood mononuclear cells.
    Kermani-Arab V; Uittenbogaart C; Bramhall J
    Thymus; 1986; 8(1-2):3-11. PubMed ID: 3487853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 1, a potential regulator of fibroblast proliferation.
    Schmidt JA; Mizel SB; Cohen D; Green I
    J Immunol; 1982 May; 128(5):2177-82. PubMed ID: 6460819
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells.
    Postlethwaite AE; Lachman LB; Kang AH
    Arthritis Rheum; 1984 Sep; 27(9):995-1001. PubMed ID: 6332633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 activity in normal human urine.
    Kimball ES; Pickeral SF; Oppenheim JJ; Rossio JL
    J Immunol; 1984 Jul; 133(1):256-60. PubMed ID: 6609981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
    Luger TA; Sztein MB; Schmidt JA; Murphy P; Grabner G; Oppenheim JJ
    Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1.
    Booth RJ; Prestidge RL; Watson JD
    J Immunol; 1983 Sep; 131(3):1289-93. PubMed ID: 6604093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony formation by lymphoid cells.
    Izaguirre CA
    Clin Haematol; 1984 Jun; 13(2):405-22. PubMed ID: 6432391
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of T- and B-lymphocyte differentiation: preliminary characterization of lymphocyte promoter factor(s) made by FCS-induced T-cell line and clones.
    Samuel D; Denizot F; Suzan M; Rubin B; Golstein P
    Cell Immunol; 1982 Jul; 71(1):139-47. PubMed ID: 6982761
    [No Abstract]   [Full Text] [Related]  

  • 14. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor- (TRF) like factor(s).
    Teranishi T; Hirano T; Arima N; Onoue K
    J Immunol; 1982 Apr; 128(4):1903-8. PubMed ID: 6801125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human interleukin 1.
    Gery I; Schmidt JA
    Methods Enzymol; 1985; 116():456-67. PubMed ID: 3878924
    [No Abstract]   [Full Text] [Related]  

  • 17. Adhesion and transcellular migration of neutrophils and B lymphocytes on fibroblasts.
    Couture P; Paradis-Massie J; Oualha N; Thibault G
    Exp Cell Res; 2009 Aug; 315(13):2192-206. PubMed ID: 19394331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and partial purification of a B cell growth-promoting material utilizing the BCL1 cell line.
    Thoman ML; Weigle WO
    J Immunol; 1983 Jan; 130(1):233-6. PubMed ID: 6600179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.
    Fontana A; Hengartner H; de Tribolet N; Weber E
    J Immunol; 1984 Apr; 132(4):1837-44. PubMed ID: 6607949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitous interleukin-1 alpha in fetal bovine serum may mislead the experimental results in vitro.
    Hida S; Takeuchi A; Hayashi H; Yano T; Hopkins SJ; Onozaki K
    Eur Cytokine Netw; 1995; 6(2):121-6. PubMed ID: 7578990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.